Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Health Promot Chronic Dis Prev Can. 2018 Oct;38(10):358-367. doi: 10.24095/hpcdp.38.10.02.
Breast cancer is detected through screening or through signs and symptoms. In Canada, mammograms for breast cancer screening are offered in organized programs or independently (opportunistic screening). Province of Ontario breast Diagnostic Assessment Units (DAUs) are facility-based programs that provide coordinated breast cancer diagnostic services, as opposed to usual care, in which the primary care provider arranges the tests and consultations. This study describes breast cancer detection method, diagnostic interval and DAU use across Ontario.
The study cohort consisted of 6898 women with invasive breast cancer diagnosed in 2011. We used the Ontario Cancer Registry linked to administrative health care databases. We determined the detection method using the Ontario Breast Screening Program (OBSP) data and physician claims. The diagnostic interval was the time between the initial screen, specialist referral or first diagnostic test and the cancer diagnosis. The diagnostic route (whether through DAU or usual care) was determined based on the OBSP records and biopsy or surgery location. We mapped the diagnostic interval and DAU coverage geographically by women's residence.
In 2011, 36% of Ontario breast cancer patients were screen-detected, with a 48% rate among those aged 50 to 69. The provincial median diagnostic interval was 32 days, with county medians ranging from 15 to 65 days. Provincially, 48.4% were diagnosed at a DAU, and this ranged from zero to 100% across counties.
The screening detection rate in age-eligible breast cancer patients was lower than published population-wide screening rates. Geographic mapping of the diagnostic interval and DAU use reveals regional variations in cancer diagnostic care that need to be addressed.
乳腺癌通过筛查或通过症状和体征进行检测。在加拿大,组织性计划或机会性筛查为乳腺癌筛查提供乳房 X 光检查。安大略省乳房诊断评估单位(DAU)是基于设施的计划,提供协调的乳腺癌诊断服务,而不是常规护理,在常规护理中,初级保健提供者安排测试和咨询。本研究描述了安大略省的乳腺癌检测方法、诊断间隔和 DAU 使用情况。
研究队列由 2011 年诊断出的 6898 名浸润性乳腺癌女性组成。我们使用安大略癌症登记处与行政医疗保健数据库相链接。我们使用安大略省乳房筛查计划(OBSP)数据和医生索赔来确定检测方法。诊断间隔是指从初始筛查、专家转诊或首次诊断测试到癌症诊断的时间。诊断途径(是通过 DAU 还是常规护理)是根据 OBSP 记录和活检或手术位置确定的。我们根据女性居住地在地理上绘制了诊断间隔和 DAU 覆盖范围。
2011 年,安大略省 36%的乳腺癌患者通过筛查发现,50 至 69 岁人群的筛查发现率为 48%。全省的中位数诊断间隔为 32 天,县中位数范围为 15 至 65 天。在全省范围内,48.4%的患者在 DAU 确诊,而各县的这一比例从 0 到 100%不等。
在符合条件的乳腺癌患者中,筛查检出率低于已发表的人群筛查率。诊断间隔和 DAU 使用情况的地理映射揭示了癌症诊断护理方面的区域差异,需要加以解决。